Pharmacoepidemiology and Drug Safety

Cover image for Vol. 23 Issue 7

Edited By: B.L. Strom, USA; J. Hasford, Germany; S Hennessy, USA; B.J. Park, Korea

Impact Factor: 2.897

ISI Journal Citation Reports © Ranking: 2012: 81/261 (Pharmacology & Pharmacy)

Online ISSN: 1099-1557

Overview


Pharmacoepidemiology and Drug Safety is the Official Journal of the International Society for Pharmacoepidemiology .


Aims and Scope


The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Communication.

Particular areas of interest include:

  • design, results, analysis and interpretation of post-marketing surveillance and other studies looking at specific drugs, populations and outcomes;
  • methods for detection and evaluation of drug-associated adverse events;
  • assessments of risk and benefit in drug therapy;
  • patterns of drug utilization;
  • relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;
  • risk management plans and programmes relating to pharmaceuticals, biologics and medical devices;
  • comparative effectiveness research relating to pharmaceuticals, biologics and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as they are truly used in the real world.

2009 Impact Factor: 2.527 (© Thomson Reuters Journal Citation Reports 2010)


Keywords


pharmacoepidemiology, drug safety, pharmacovigilance, postmarketing surveillance, epidemiology, pharmacology, pharmaceutical, biostatistics, risk-benefit ratio, adverse events, journal, online journal, Wiley Online Library


Abstracting and Indexing Information

  • Abstracts in Anthropology (Baywood Publishing)
  • Biological Abstracts (Thomson Reuters)
  • BIOSIS Previews (Thomson Reuters)
  • CAS: Chemical Abstracts Service (ACS)
  • Chemical Abstracts Service/SciFinder (ACS)
  • CSA Biological Sciences Database (ProQuest)
  • CSA Environmental Sciences & Pollution Management Database (ProQuest)
  • Current Contents: Clinical Medicine (Thomson Reuters)
  • Current Index to Statistics (ASA/IMS)
  • Embase (Elsevier)
  • Environment Index (EBSCO Publishing)
  • HEED: Health Economic Evaluations Database (Wiley-Blackwell)
  • IDIS: Iowa Drug Information Service (University of Iowa)
  • Index Medicus/MEDLINE (NLM)
  • International Pharmaceutical Abstracts (Thomson Reuters)
  • Journal Citation Reports/Science Edition (Thomson Reuters)
  • MEDLINE/PubMed (NLM)
  • Neurosciences Abstracts (ProQuest)
  • PASCAL Database (INIST/CNRS)
  • Science Citation Index (Thomson Reuters)
  • Science Citation Index Expanded (Thomson Reuters)
  • SCOPUS (Elsevier)
  • SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica)
  • Web of Science (Thomson Reuters)

SEARCH

SEARCH BY CITATION